Effects of DPP-4 Inhibitors on Blood Glucose Variability in Japanese Patients with Type 2 Diabetes on Maintenance Hemodialysis: A Prospective Observational Exploratory Study

INTRODUCTION: The precise blood glucose (BG) profile of hemodialysis patients is unclear, as is the effectiveness of dipeptidyl peptidase-4 (DPP-4) inhibitors in hemodialysis patients with type 2 diabetes. Here, we used continuous glucose monitoring (CGM) to evaluate BG variability in these patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa-Tanaka, Tomomi, Hosojima, Michihiro, Kabasawa, Hideyuki, Kaseda, Ryohei, Yasukawa, Ryota, Yata, Yusuke, Kuwahara, Shoji, Kono, Emiko, Takata, Takuma, Iino, Noriaki, Tanaka, Takahiro, Kitamura, Nobutaka, Suzuki, Yoshiki, Saito, Akihiko, Narita, Ichiei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644617/
https://www.ncbi.nlm.nih.gov/pubmed/33000383
http://dx.doi.org/10.1007/s13300-020-00928-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644617/
https://www.ncbi.nlm.nih.gov/pubmed/33000383
http://dx.doi.org/10.1007/s13300-020-00928-5

Ejemplares similares